India Biosimilars Market: A $1.5 Billion Opportunity for Pharma Startups & MSMEs
Introduction: India Biosimilars Market India has now graduated from being merely "the pharmacy of the world" for generic medicines to also becoming the most favoured country to manufacture high-value, complex ...